Physiologically-Based Pharmacokinetic Modeling and Bioactivation of Xenobiotics
暂无分享,去创建一个
[1] M E Andersen,et al. Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements. , 1980, Toxicology and applied pharmacology.
[2] A. Monro,et al. What is an appropriate measure of exposure when testing drugs for carcinogenicity in rodents? , 1992, Toxicology and applied pharmacology.
[3] M. Andersen,et al. Inhalation pharmacokinetics: evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios. , 1984, Toxicology and applied pharmacology.
[4] H J Clewell,et al. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. , 1986, Toxicology and applied pharmacology.
[5] Melvin E. Andersen,et al. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphate , 1990 .
[6] M E Andersen,et al. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. , 1989, Toxicology and applied pharmacology.
[7] H J Clewell,et al. A physiological pharmacokinetic model for dermal absorption of vapors in the rat. , 1986, Toxicology and applied pharmacology.
[8] M E Andersen,et al. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.
[9] R. D. Stewart,et al. Human exposure to styrene vapor. , 1968, Archives of environmental health.
[10] A Sato,et al. Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. , 1979, British journal of industrial medicine.
[11] M. Gargas. An Exhaled Breath Chamber System for Assessing Rates of Metabolism and Rates of Gastrointestinal Absorption with Volatile Compounds , 1990 .
[12] R H Reitz,et al. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.
[13] L S Birnbaum,et al. Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species. , 1983, Toxicology and applied pharmacology.
[14] M. Andersen,et al. Metabolism of inhaled brominated hydrocarbons: validation of gas uptake results by determination of a stable metabolite. , 1982, Toxicology and applied pharmacology.
[15] J. Young,et al. Pharmacokinetics of inhaled styrene in rats and humans. , 1978, Scandinavian journal of work, environment & health.
[16] R L Dedrick,et al. Species similarities in pharmacokinetics. , 1980, Federation proceedings.
[17] H W Leung,et al. Development and utilization of physiologically based pharmacokinetic models for toxicological applications. , 1991, Journal of toxicology and environmental health.
[18] Torsten Teorell,et al. Kinetics of distribution of substances administered to the body, II : The intravascular modes of administration , 1937 .
[19] H J Clewell,et al. Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing. , 1993, Toxicology letters.
[20] M E Andersen,et al. Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. , 1988, The Journal of pharmacology and experimental therapeutics.
[21] H J Clewell,et al. A physiologically based simulation approach for determining metabolic constants from gas uptake data. , 1986, Toxicology and applied pharmacology.
[22] H J Clewell,et al. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate. , 1990, Toxicology and applied pharmacology.
[23] Melvin E. Andersen,et al. A Multiple Dose-Route Physiological Pharmacokinetic Model for Volatile Chemicals Using ACSL/PC, , 1986 .
[24] P. Watanabe,et al. Fate of (14C)vinyl chloride after single oral administration in rats. , 1976, Toxicology and applied pharmacology.
[25] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[26] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[27] D J Paustenbach,et al. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. , 1988, Toxicology and applied pharmacology.
[28] H J Clewell,et al. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.
[29] J. Young,et al. Pharmacokinetics of inhaled styrene in human volunteers. , 1980, Toxicology and applied pharmacology.
[30] M E Andersen,et al. Development of a physiologically based pharmacokinetic model for chloroform. , 1990, Toxicology and applied pharmacology.
[31] D. H. Taylor,et al. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1990, Toxicology and applied pharmacology.
[32] E. Adolph,et al. Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.
[33] M E Andersen,et al. Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.
[34] H. Matthews,et al. Distribution and excretion of 2,2',4,4',5,5'-hexabromobiphenyl in rats and man: pharmacokinetic model predictions. , 1980, Toxicology and applied pharmacology.
[35] H J Clewell,et al. Improving toxicology testing protocols using computer simulations. , 1989, Toxicology letters.
[36] M E Andersen,et al. Biologically based pharmacodynamic models: tools for toxicological research and risk assessment. , 1991, Annual review of pharmacology and toxicology.
[37] D J Paustenbach,et al. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. , 1988, Toxicology letters.
[38] A Sato,et al. A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. , 1979, Toxicology and applied pharmacology.
[39] M E Andersen,et al. Saturable metabolism and its relationship to toxicity. , 1981, Critical reviews in toxicology.
[40] H J Clewell,et al. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. , 1991, Toxicology and applied pharmacology.
[41] H J Clewell,et al. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. , 1987, Toxicology and applied pharmacology.
[42] R. Lutz,et al. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model. , 1984, Drug metabolism and disposition: the biological fate of chemicals.